© Copyright 2025 American Medical Association. All rights reserved.
| Short Descr | ADM SARSCOV2 30MCG/0.3ML BST | Medium Descr | IMM ADMN SARSCOV2 30MCG/0.3ML DIL RECON BST DOSE | Long Descr | Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; booster dose | Status Code | Not Valid for Medicare Purposes | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Non-Covered Service, not paid under OPPS | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. |
| 59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. | CR | Catastrophe/disaster related | GV | Attending physician not employed or paid under arrangement by the patient's hospice provider | GW | Service not related to the hospice patient's terminal condition | QJ | Services/items provided to a prisoner or patient in state or local custody, however the state or local government, as applicable, meets the requirements in 42 cfr 411.4 (b) |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2025-01-01 | Deleted | First appearance of code deletion in codebook. |
| 2025-01-01 | Note | First appearance of code deletion in codebook. |
| 2024-01-01 | Added | First appearance of 2022 AMA guideline updates in codebook. |
| 2023-11-01 | Deleted | Code deleted. To report administration of COVID-19 vaccine, use 90480. |
| 2023-05-01 | Note | Changes made to dosing information. |
| 2023-04-18 | Note | No longer authorized for use in the United States. |
| 2023-04-18 | Note | These codes (previously associated with 0004A) are no longer authorized for use in the United States: 91300, 91305, 91307, 91308. |
| 2023-01-01 | Note | First appearance of guideline change(s) in codebook. |
| 2023-01-01 | Added | First appearance in codebook. |
| 2022-12-08 | Note | AMA guideline changed to include 91317. Published to website 2021-12-09. Received FDA approval effective retroactively to 2022-12-08. |
| 2022-10-12 | Note | AMA Guideline changed. 91315 received FDA approval. |
| 2022-08-31 | Note | AMA guideline changed to include 91312, 91315 effective upon receiving emergency Use Authorization or approval from the FDA. |
| 2022-08-31 | Note | AMA Guideline changed. 91312 received FDA approval. |
| 2022-08-31 | Note | Changes made to vaccine name, product & dosing information, & patient age to (12+). |
| 2022-06-17 | Note | AMA Guideline changed. 91308 received approval. |
| 2022-02-01 | Note | AMA guideline changed to include 91308 effective upon receiving Emergency Use Authorization or approval from the FDA |
| 2021-10-29 | Note | Codes 91305 & 91307 authorization granted. |
| 2021-10-06 | Note | AMA guideline changed to include 91307 (effective upon receiving Emergency Use Authorization or approval from the FDA.) |
| 2021-09-22 | Added | FDA approval received. |
| 2021-09-03 | Note | AMA guidelines added to include 0001A, 0002A, 0003A, 91300. These codes were published to AMA website and received FDA approval prior to addition of the guideline. |
| 2021-09-03 | Added | Published on AMA website. Effective upon receiving Emergency Use Authorization or approval from the Food and Drug Administration. |
Get instant expert-level medical coding assistance.